Lanean...

Immuno-oncology combinations: raising the tail of the survival curve

There have been exponential gains in immuno-oncology in recent times through the development of immune checkpoint inhibitors. Already approved by the U.S. Food and Drug Administration for advanced melanoma and non-small cell lung cancer, immune checkpoint inhibitors also appear to have significant a...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Cancer Biol Med
Egile Nagusiak: Harris, Samuel J., Brown, Jessica, Lopez, Juanita, Yap, Timothy A.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Chinese Anti-Cancer Association 2016
Gaiak:
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4944548/
https://ncbi.nlm.nih.gov/pubmed/27458526
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.20892/j.issn.2095-3941.2016.0015
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!